Mayo Clinic Q&A: Bringing COVID-19 Vaccines to the Public

Everyone
  • 1 video | 15m 45s
Likes 42 Likes 42
Once a vaccine to prevent COVID-19 is approved, there will be logistics to consider. For example, who will receive the vaccine first, and how can the supply chain safely deliver the vaccine to 330 million Americans and potentially more than 7 billion people worldwide? In addition, multiple vaccines may be brought to market within weeks to months of each other, confusing consumers. (Published 9/16/2020)

IN THIS COURSE

  • 15m 45s
    On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious disease expert and head of Mayo Clinic's Vaccine Research Group, explains the challenges of rolling out a COVID-19 vaccine. (Published 9/16/2020) FREE ACCESS

YOU MIGHT ALSO LIKE

Course Mayo Clinic Q&A: COVID-19 vaccine confidence and the importance of that second dose
Likes 28 Likes 28  
Audiobook COVID-19 Miniseries: Mayo Clinic Q&A -- Expert Updates on COVID-19 Vaccines
Course Mayo Clinic Q&A: Strict adherence to public health measures effective in combating COVID-19
Likes 17 Likes 17  

PEOPLE WHO VIEWED THIS ALSO VIEWED THESE

Course Mayo Clinic Q&A: Answering Questions about COVID-19 Vaccines
Likes 32 Likes 32  
Course Mayo Clinic Q&A: COVID-19 Weekly Update
Likes 33 Likes 33  
Course Mayo Clinic Q&A: COVID-19 Vaccinations Happening in Phases
Likes 31 Likes 31